Experiment: 8B1X

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D HNCO	100 uM [U-100% 13C; U-100% 15N] P3-7_2	90% H2O/10% D2O	180 mM	7.4	ambient atm	278	Bruker AVANCE II 600
2	3D (H)CC(CO)NH TOCSY	100 uM [U-100% 13C; U-100% 15N] P3-7_2	90% H2O/10% D2O	180 mM	7.4	ambient atm	278	Bruker AVANCE II 600
3	3D (H)CC(CA)NH TOCSY	100 uM [U-100% 13C; U-100% 15N] P3-7_2	90% H2O/10% D2O	180 mM	7.4	ambient atm	278	Bruker AVANCE II 600
4	3D CNH-NOESY	100 uM [U-100% 13C; U-100% 15N] P3-7_2	90% H2O/10% D2O	180 mM	7.4	ambient atm	278	Bruker AVANCE NEO 800
5	3D 1H-15N NOESY	100 uM [U-100% 13C; U-100% 15N] P3-7_2	90% H2O/10% D2O	180 mM	7.4	ambient atm	278	Bruker AVANCE NEO 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE II	600
2	Bruker	AVANCE NEO	800

NMR Refinement
Method	Details	Software
molecular dynamics		CoMAND

NMR Ensemble Information
Conformer Selection Criteria	back calculated data agree with experimental NOESY spectrum
Conformers Calculated Total Number	7
Conformers Submitted Total Number	7
Representative Model	1 (medoid)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin		Bruker Biospin
2	processing	TopSpin		Bruker Biospin
3	data analysis	Sparky		Goddard
4	structure calculation	CoMAND	2.1	ElGamacy, Riss, Zhu, Truffault, Coles
6	chemical shift assignment	Sparky		Goddard

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.